XML 55 R47.htm IDEA: XBRL DOCUMENT v3.24.3
Business Combination - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Jan. 05, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Business Acquisition [Line Items]              
Revenue   $ 22,900   $ 61,500      
Loss   1,600   $ 30,600      
Acquisition-related transaction cost   $ 5,079 $ 1,666   $ 25,024 $ 1,666  
Common stock, par value (in dollars per share)   $ 0.001   $ 0.001 $ 0.001   $ 0.001
Minimum              
Business Acquisition [Line Items]              
Cumulative discounted cash flow percentage         85.00%    
Maximum              
Business Acquisition [Line Items]              
Cumulative discounted cash flow percentage         90.00%    
Selling, general and administrative expense              
Business Acquisition [Line Items]              
Transaction bonuses incurred         $ 1,900    
Transaction and integration expenses              
Business Acquisition [Line Items]              
Acquisition-related transaction cost         $ 12,300    
Common Stock | SomaLogic Inc.              
Business Acquisition [Line Items]              
Common stock, par value (in dollars per share) $ 0.0001            
Standard BioTools              
Business Acquisition [Line Items]              
Exchanged common stock $ 1.11            
Amount of common stock $ 188,808            
Value of consideration transferred 444,219            
Standard BioTools | Common Stock              
Business Acquisition [Line Items]              
Amount of common stock $ 419,200            
Common stock, par value (in dollars per share) $ 0.001